XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Current Assets    
Cash and cash equivalents $ 859 $ 563
Funds deposited by counterparties 11 33
Restricted cash 15 17
Accounts receivable, net 898 1,024
Inventory 391 412
Derivative instruments 611 764
Cash collateral paid in support of energy risk management activities 388 287
Prepayments and other current assets 285 302
Current assets - held for sale 0 1
Current assets - discontinued operations 0 197
Total current assets 3,458 3,600
Property, plant and equipment, net 2,650 3,048
Other Assets    
Equity investments in affiliates 387 412
Operating lease right-of-use assets, net 517 0
Goodwill 573 573
Intangible assets, net 580 591
Nuclear decommissioning trust fund 718 663
Derivative instruments 347 317
Deferred income taxes 45 46
Other non-current assets 255 289
Non-current assets - held-for-sale 0 77
Non-current assets - discontinued operations 0 1,012
Total other assets 3,422 3,980
Total Assets 9,530 10,628
Current Liabilities    
Current portion of long-term debt and capital leases 124 72
Current portion of operating lease liabilities 74 0
Accounts payable 697 863
Derivative instruments 489 673
Cash collateral received in support of energy risk management activities 11 33
Accrued expenses and other current liabilities 550 680
Current liabilities - held-for-sale 0 5
Current liabilities - discontinued operations 0 72
Total current liabilities 1,945 2,398
Other Liabilities    
Long-term debt and capital leases 6,366 6,449
Non-current operating lease liabilities 529 0
Nuclear decommissioning reserve 286 282
Nuclear decommissioning trust liability 423 371
Derivative instruments 350 304
Deferred income taxes 62 65
Other non-current liabilities 1,089 1,274
Non-current liabilities - held-for-sale 0 65
Non-current liabilities - discontinued operations 0 635
Total other liabilities 9,105 9,445
Total Liabilities 11,050 11,843
Redeemable noncontrolling interest in subsidiaries 18 19
Commitments and Contingencies
Stockholders’ Equity    
Common stock; $0.01 par value; 500,000,000 shares authorized; 421,786,061 and 420,288,886 shares issued and 267,538,257 and 283,650,039 shares outstanding at March 31, 2019 and December 31, 2018, respectively 4 4
Additional paid-in capital 8,473 8,510
Accumulated deficit (5,548) (6,022)
Less treasury stock, at cost - 154,247,804 and 136,638,847 shares at March 31, 2019 and December 31, 2018, respectively (4,371) (3,632)
Accumulated other comprehensive loss (96) (94)
Total Stockholders’ Equity (1,538) (1,234)
Total Liabilities and Stockholders’ Equity $ 9,530 $ 10,628